Oncology

A novel deep learning approach to body composition analysis may offer a cost-effective and clinically relevant method to predict treatment outcomes in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to findings from the LOTIS-2 trial.

The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.

Subcutaneous (SC) delivery of immunotherapies for solid tumors has emerged as a potentially transformative approach to cancer treatment, promising comparable clinical efficacy to intravenous (IV) therapies while significantly reducing treatment time and burden on healthcare systems.

An artificial intelligence tool trained on digital pathology slides has demonstrated clinical-grade accuracy for detecting EGFR mutations in lung adenocarcinoma and significantly reduced reliance on molecular testing, according to results from a large-scale real-world deployment study.

Modulating the gut microbiome may enhance immunotherapy responses in patients with solid tumors, according to a recent review exploring emerging evidence across melanoma, renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC).

Disparities in the use of patient portal messaging remain prevalent among oncology patients, even among those who are already enrolled, according to a large retrospective study from an urban academic cancer center.

Sexual health problems are highly prevalent and distressing among breast cancer survivors, yet the majority of women report receiving little to no support from their healthcare teams, according to findings from the WISH-BREAST survey.

A nationwide study of basal cell carcinoma (BCC) excisions in Denmark found that hospital-based specialists have significantly lower odds of incomplete removal than their practice-based peers, raising important questions about treatment setting and provider expertise.